share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K:重大事件
美股sec公告 ·  05/17 00:16
牛牛AI助理已提取核心訊息
On May 14, 2024, Assure Holdings Corp. reconvened its previously adjourned special meeting of stockholders, where a significant resolution was passed. Shareholders approved an amendment to the Company's Articles of Incorporation, which will increase the authorized shares of common stock from 9,000,000 to 250,000,000. The approval was achieved with 5,226,969 votes in favor, 194,592 against, and 5,901 abstentions. This move is part of Assure's strategy to merge with Danam Health and maintain its NASDAQ listing. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. In addition, Assure issued a press release on May 16, 2024, to announce the stockholder approval of the increase in authorized shares. The press release also serves as a reminder of the proposed transactions between Assure...Show More
On May 14, 2024, Assure Holdings Corp. reconvened its previously adjourned special meeting of stockholders, where a significant resolution was passed. Shareholders approved an amendment to the Company's Articles of Incorporation, which will increase the authorized shares of common stock from 9,000,000 to 250,000,000. The approval was achieved with 5,226,969 votes in favor, 194,592 against, and 5,901 abstentions. This move is part of Assure's strategy to merge with Danam Health and maintain its NASDAQ listing. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. In addition, Assure issued a press release on May 16, 2024, to announce the stockholder approval of the increase in authorized shares. The press release also serves as a reminder of the proposed transactions between Assure and Danam Health Inc., for which relevant materials have been filed with the SEC, including a registration statement on Form S-4 containing a prospectus and a proxy statement. The documents are essential for investors and security holders, providing important information about the proposed transactions. The Company's CEO, John Farlinger, expressed gratitude to the stockholders for their support, which enables the management to execute their strategic plans.
2024年5月14日,Assure Holdings Corp. 重新召開了先前休會的股東特別會議,會上通過了一項重要決議。股東批准了公司章程的修正案,該修正案將把普通股的法定股數從9,000,000股增加到2.5億股。以5,226,969張贊成票、194,592票反對和5,901張棄權票獲得批准。此舉是Assure與達南健康合併並維持其在納斯達克上市的戰略的一部分。該公司計劃立即提交修正案,以實現授權普通股的增加。此外,Assure於2024年5月16日發佈了一份新聞稿,宣佈股東批准增加授權股份。該新聞稿還提醒人們注意Assure和Danam Health Inc. 之間的擬議交易,相關材料已向美國證券交易委員會提交,包括一份包含招股說明書和委託書的S-4表格註冊聲明。這些文件對投資者和證券持有人至關重要,提供了有關擬議交易的重要信息。公司首席執行官約翰·法林格對股東的支持表示感謝,這使管理層能夠執行其戰略計劃。
2024年5月14日,Assure Holdings Corp. 重新召開了先前休會的股東特別會議,會上通過了一項重要決議。股東批准了公司章程的修正案,該修正案將把普通股的法定股數從9,000,000股增加到2.5億股。以5,226,969張贊成票、194,592票反對和5,901張棄權票獲得批准。此舉是Assure與達南健康合併並維持其在納斯達克上市的戰略的一部分。該公司計劃立即提交修正案,以實現授權普通股的增加。此外,Assure於2024年5月16日發佈了一份新聞稿,宣佈股東批准增加授權股份。該新聞稿還提醒人們注意Assure和Danam Health Inc. 之間的擬議交易,相關材料已向美國證券交易委員會提交,包括一份包含招股說明書和委託書的S-4表格註冊聲明。這些文件對投資者和證券持有人至關重要,提供了有關擬議交易的重要信息。公司首席執行官約翰·法林格對股東的支持表示感謝,這使管理層能夠執行其戰略計劃。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。